DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Glaucoma Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.
US Glaucoma Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Glaucoma pipeline products, Glaucoma epidemiology, Glaucoma market valuations and forecast, Glaucoma products sales and competitive landscape in the US.
The research is classified into nine sections - Glaucoma overview including etiology, pathophysiology, and diagnosis, Glaucoma treatment options, Glaucoma pipeline products, Glaucoma market analysis comprising of Glaucoma epidemiology, key products marketed for Glaucoma, market valuations and forecast, products sales and market shares.
- Glaucoma Pipeline: Find out the products in clinical trials for the treatment of Glaucoma by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Glaucoma Epidemiology: Find out the number of patients diagnosed (prevalence) with Glaucoma in the US
- Glaucoma Products: Identify key products marketed and prescribed for Glaucoma in the US, including trade name, molecule name, and company
- Glaucoma Product Sales: Find out the sales revenues of Glaucoma products, both branded and generics, in the US
- Glaucoma Market Valuations: Find out the market size for Glaucoma products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
- Glaucoma Products Market Share: Find out the market shares for key Glaucoma products in the US
Key Topics Covered:
- Disease Overview
- Glaucoma Treatments
- Glaucoma Pipeline
- US Glaucoma Epidemiology
- Marketed Drugs for Glaucoma in US
- US Glaucoma Market Size
- US Glaucoma Products Sales
- US Glaucoma Market Competitive Landscape
- US Glaucoma Market Forecast
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/54rhff/us_glaucoma